Lexaria Bioscience Corp (LEXX)
3.54
+0.11
(+3.21%)
USD |
NASDAQ |
May 08, 16:00
3.54
0.00 (0.00%)
After-Hours: 16:12
Lexaria Bioscience Cash from Operations (Quarterly): -0.6196M for Feb. 29, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -0.6196M |
| November 30, 2023 | -1.182M |
| August 31, 2023 | -1.622M |
| May 31, 2023 | -1.786M |
| February 28, 2023 | -1.228M |
| November 30, 2022 | -1.245M |
| August 31, 2022 | -1.177M |
| May 31, 2022 | -1.259M |
| February 28, 2022 | -1.277M |
| November 30, 2021 | -1.166M |
| August 31, 2021 | -1.112M |
| May 31, 2021 | -1.157M |
| February 28, 2021 | -0.9112M |
| November 30, 2020 | -0.8095M |
| August 31, 2020 | -0.6393M |
| May 31, 2020 | -0.6705M |
| February 29, 2020 | -0.7539M |
| November 30, 2019 | -0.5551M |
| August 31, 2019 | -0.7366M |
| May 31, 2019 | -1.101M |
| February 28, 2019 | -0.6033M |
| November 30, 2018 | -0.5643M |
| August 31, 2018 | -0.8371M |
| May 31, 2018 | -0.5597M |
| February 28, 2018 | -0.6009M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.5203M |
| August 31, 2017 | -0.3533M |
| May 31, 2017 | -0.6035M |
| February 28, 2017 | -0.4881M |
| November 30, 2016 | -0.101M |
| August 31, 2016 | -0.2608M |
| May 31, 2016 | -0.1083M |
| February 29, 2016 | -0.0828M |
| November 30, 2015 | -0.2089M |
| August 31, 2015 | -0.5809M |
| May 31, 2015 | -0.3861M |
| February 28, 2015 | -0.3609M |
| November 30, 2014 | -0.1732M |
| July 31, 2014 | -0.2229M |
| April 30, 2014 | -0.0969M |
| January 31, 2014 | -0.0919M |
| October 31, 2013 | 0.0743M |
| July 31, 2013 | 0.0603M |
| April 30, 2013 | 0.124M |
| January 31, 2013 | 0.0625M |
| October 31, 2012 | 0.2036M |
| July 31, 2012 | 0.0478M |
| April 30, 2012 | -0.0699M |
| January 31, 2012 | -0.0455M |
| October 31, 2011 | 0.2929M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-1.786M
Minimum
May 2023
-0.5551M
Maximum
Nov 2019
-1.050M
Average
-1.134M
Median
Cash from Operations (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 14.31M |
| Sunshine Biopharma Inc | -2.690M |
| Acasti Pharma Inc | -1.892M |
| Edesa Biotech Inc | -1.406M |
| Xenon Pharmaceuticals Inc | -35.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.057M |
| Cash from Financing (Quarterly) | 3.453M |
| Free Cash Flow | -5.408M |
| Free Cash Flow Per Share (Quarterly) | -0.0629 |
| Free Cash Flow to Equity (Quarterly) | -0.6766M |
| Free Cash Flow Yield | -17.78% |